Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
FEMALE
NCT06085404

Patients Derived Organoids in Ovarian Cancer

Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-03-04

48

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Among cancer models, patients derived organoids (PDOs) best reproduce tumor's tissue architecture, intratumor heterogeneity and are able to mimic in vivo patients' drugs response. For these reasons, it has been designed a study to assess the feasibility of PDOs immune cells co-culture in OC patients and the concordance between ex vivo sensitivity and in vivo treatment response. If proven effective and reliable, PDOs could be introduced into clinical practice as empirical predictor of patients' response to antineoplastic drugs.

CONDITIONS

Official Title

Patients Derived Organoids in Ovarian Cancer

Who Can Participate

Age: 18Years - 80Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Preoperative clinical, serological and radiologic suspicion of International Federation of Gynecology and Obstetrics (FIGO) stage IIIC or greater ovarian, fallopian tube, or primary peritoneal cancer
  • Histologic diagnoses of epithelial ovarian cancer at frozen section
  • Age greater than 18 years
  • Estimated life expectancy of at least 4 weeks
  • Performance status (PS) according to Eastern Cooperative Oncology Group (ECOG) less than 2
Not Eligible

You will not qualify if you...

  • Non-serous histology at frozen section
  • Diagnosis of immunodeficiency
  • Receiving chronic systemic steroid therapy (more than 10 mg equivalent prednisone daily)
  • Receiving any other form of immunosuppressive therapy within 7 days prior to enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Policlinico Universitario Agostino Gemelli

Roma, Italy

Actively Recruiting

Loading map...

Research Team

C

Camilla Nero, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Patients Derived Organoids in Ovarian Cancer | DecenTrialz